• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

路易体痴呆症中与淀粉样变性相关的决策缺陷。

Decision-Making Deficits Associated with Amyloidosis in Lewy Body Disorders.

作者信息

Spotorno Nicola, McMillan Corey T, Irwin David J, Clark Robin, Lee Edward B, Trojanowski John Q, Weintraub Daniel, Grossman Murray

机构信息

Penn Frontotemporal Degeneration Center, University of Pennsylvania Perelman School of MedicinePhiladelphia, PA, USA; Brain Plasticity and Neurodegeneration Group, German Center for Neurodegenerative Diseases (DZNE)Magdeburg, Germany.

Penn Frontotemporal Degeneration Center, University of Pennsylvania Perelman School of Medicine Philadelphia, PA, USA.

出版信息

Front Hum Neurosci. 2017 Jan 11;10:693. doi: 10.3389/fnhum.2016.00693. eCollection 2016.

DOI:10.3389/fnhum.2016.00693
PMID:28123364
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5225123/
Abstract

Lewy body disorders (LBD) are clinical syndromes characterized by pathological inclusions containing α-synuclein. Cognitive deficits are common or diagnostic in LBD, and may be associated with the presence of beta-amyloid (Aβ), which is a hallmark histopathologic abnormality characteristic of Alzheimer's disease (AD) that can also co-occur with LBD. In the present study we evaluated whether social decision-making difficulties in LBD are associated with Aβ burden. Decision-making abilities were measured with a simple, untimed, behavioral task previously validated in patients with behavioral variant frontotemporal dementia, and performance was related to gray matter atrophy on MRI. Aβ burden was assessed by examination of cerebrospinal fluid (CSF) level of Aβ and by autopsy confirmation in a subgroup of patients. The results revealed that LBD patients with evidence of Aβ have reduced social decision-making abilities compared to patients with no evidence of Aβ. The imaging analysis related greater decision-making difficulty in Aβ-positive patients in respect to Aβ-negative patients to gray matter atrophy in medial orbitofrontal. This region is a critical node of a decision-making network as well as a region previously associated with comorbid α-synuclein and Aβ in LBD. These preliminary findings suggest that cognitive difficulties in LBD extend to include deficits in social decision-making and that this may be related to the presence of Aβ.

摘要

路易体障碍(LBD)是一类临床综合征,其特征为含有α-突触核蛋白的病理性包涵体。认知缺陷在LBD中很常见或具有诊断意义,并且可能与β-淀粉样蛋白(Aβ)的存在有关,Aβ是阿尔茨海默病(AD)标志性的组织病理学异常特征,也可与LBD同时出现。在本研究中,我们评估了LBD患者的社会决策困难是否与Aβ负担相关。使用一项先前在行为变异型额颞叶痴呆患者中验证过的简单、无时间限制的行为任务来测量决策能力,并且将表现与MRI上的灰质萎缩相关联。通过检测脑脊液(CSF)中Aβ水平以及在一组患者中进行尸检确认来评估Aβ负担。结果显示,与无Aβ证据的患者相比,有Aβ证据的LBD患者的社会决策能力降低。成像分析表明,Aβ阳性患者相对于Aβ阴性患者决策困难更大,这与内侧眶额皮质的灰质萎缩有关。该区域是决策网络的关键节点,也是先前与LBD中共存的α-突触核蛋白和Aβ相关的区域。这些初步发现表明,LBD患者的认知困难扩展到包括社会决策缺陷,并且这可能与Aβ的存在有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf5/5225123/ce3b027c77ae/fnhum-10-00693-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf5/5225123/dc991b4f71d9/fnhum-10-00693-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf5/5225123/ce3b027c77ae/fnhum-10-00693-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf5/5225123/dc991b4f71d9/fnhum-10-00693-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bf5/5225123/ce3b027c77ae/fnhum-10-00693-g0002.jpg

相似文献

1
Decision-Making Deficits Associated with Amyloidosis in Lewy Body Disorders.路易体痴呆症中与淀粉样变性相关的决策缺陷。
Front Hum Neurosci. 2017 Jan 11;10:693. doi: 10.3389/fnhum.2016.00693. eCollection 2016.
2
Shared decision-making interventions for people with mental health conditions.心理健康问题患者的共同决策干预措施。
Cochrane Database Syst Rev. 2022 Nov 11;11(11):CD007297. doi: 10.1002/14651858.CD007297.pub3.
3
Cholinesterase inhibitors for dementia with Lewy bodies.用于路易体痴呆的胆碱酯酶抑制剂。
Cochrane Database Syst Rev. 2003;2003(3):CD003672. doi: 10.1002/14651858.CD003672.
4
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
5
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
6
Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without dementia.抗血栓治疗预防神经影像学检查发现的小血管疾病但无痴呆的患者认知能力下降。
Cochrane Database Syst Rev. 2022 Jul 14;7(7):CD012269. doi: 10.1002/14651858.CD012269.pub2.
7
Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.在痴呆症患者中,停用或继续使用胆碱酯酶抑制剂、美金刚或两者。
Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD009081. doi: 10.1002/14651858.CD009081.pub2.
8
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.纤维素、改性纤维素和合成膜在终末期肾病患者血液透析中的比较。
Cochrane Database Syst Rev. 2001(3):CD003234. doi: 10.1002/14651858.CD003234.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
Hormone replacement therapy to maintain cognitive function in women with dementia.激素替代疗法用于维持痴呆女性的认知功能。
Cochrane Database Syst Rev. 2002(3):CD003799. doi: 10.1002/14651858.CD003799.

引用本文的文献

1
A Complex Relationship Between Suicide, Dementia, and Amyloid: A Narrative Review.自杀、痴呆症与淀粉样蛋白之间的复杂关系:一篇叙述性综述
Front Neurosci. 2018 Jun 1;12:371. doi: 10.3389/fnins.2018.00371. eCollection 2018.

本文引用的文献

1
Dissociation of quantifiers and object nouns in speech in focal neurodegenerative disease.局灶性神经退行性疾病中言语中量词与宾语名词的分离
Neuropsychologia. 2016 Aug;89:141-152. doi: 10.1016/j.neuropsychologia.2016.06.013. Epub 2016 Jun 11.
2
Presence of cerebral amyloid modulates phenotype and pattern of neurodegeneration in early Parkinson's disease.脑淀粉样蛋白的存在调节早期帕金森病中神经变性的表型和模式。
J Neurol Neurosurg Psychiatry. 2016 Oct;87(10):1112-22. doi: 10.1136/jnnp-2015-312690. Epub 2016 Jun 9.
3
Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease.
用于识别早期阿尔茨海默病的淀粉样蛋白PET和脑脊液生物标志物的详细比较。
Neurology. 2015 Oct 6;85(14):1240-9. doi: 10.1212/WNL.0000000000001991. Epub 2015 Sep 9.
4
Getting on the same page: the neural basis for social coordination deficits in behavioral variant frontotemporal degeneration.达成共识:行为变异型额颞叶痴呆社会协调缺陷的神经基础
Neuropsychologia. 2015 Mar;69:56-66. doi: 10.1016/j.neuropsychologia.2015.01.028. Epub 2015 Jan 22.
5
Perceptual decision-making in patients with Parkinson's disease.帕金森病患者的知觉决策
J Psychopharmacol. 2014 Dec;28(12):1149-54. doi: 10.1177/0269881114548437. Epub 2014 Sep 18.
6
Executive dysfunction in Parkinson's disease: a review.帕金森病的执行功能障碍:综述。
J Neuropsychol. 2013 Sep;7(2):193-224. doi: 10.1111/jnp.12028.
7
Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies.帕金森病痴呆:α-突触核蛋白、tau 和淀粉样β 病理学的汇聚。
Nat Rev Neurosci. 2013 Sep;14(9):626-36. doi: 10.1038/nrn3549. Epub 2013 Jul 31.
8
Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid.比较正电子发射断层扫描成像与β-淀粉样蛋白的脑脊液测量。
Ann Neurol. 2013 Dec;74(6):826-36. doi: 10.1002/ana.23908.
9
Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia.淀粉样蛋白与无痴呆的帕金森病患者的认知能力下降有关。
Neurology. 2013 Jan 1;80(1):85-91. doi: 10.1212/WNL.0b013e31827b1a07. Epub 2012 Dec 12.
10
100 years of Lewy pathology.路易体病 100 年。
Nat Rev Neurol. 2013 Jan;9(1):13-24. doi: 10.1038/nrneurol.2012.242. Epub 2012 Nov 27.